垂体神经内分泌肿瘤中 Ki-67 和有丝分裂的评估--一致性计数。

IF 5.8 2区医学 Q1 CLINICAL NEUROLOGY Brain Pathology Pub Date : 2024-07-15 DOI:10.1111/bpa.13285

Paul Benjamin Loughrey, Christine Greene, Kris D. McCombe, Fatima Abdullahi Sidi, Stephen McQuaid, Stephen Cooke, Steven J. Hunter, Brian Herron, Márta Korbonits, Stephanie G. Craig, Jacqueline A. James

{"title":"垂体神经内分泌肿瘤中 Ki-67 和有丝分裂的评估--一致性计数。","authors":"Paul Benjamin Loughrey, Christine Greene, Kris D. McCombe, Fatima Abdullahi Sidi, Stephen McQuaid, Stephen Cooke, Steven J. Hunter, Brian Herron, Márta Korbonits, Stephanie G. Craig, Jacqueline A. James","doi":"10.1111/bpa.13285","DOIUrl":null,"url":null,"abstract":"<p>Pituitary neuroendocrine tumour Ki-67 proliferation index varies according to the number of tumour cells assessed. Consistent Ki-67 scoring approaches and re-evaluation of the recommended Ki-67 3% cut-off are required to clarify controversies in pituitary neuroendocrine tumour Ki-67 proliferation index assessment.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":9290,"journal":{"name":"Brain Pathology","volume":"35 1","pages":""},"PeriodicalIF":5.8000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669404/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessment of Ki-67 and mitoses in pituitary neuroendocrine tumours—Consistency counts\",\"authors\":\"Paul Benjamin Loughrey, Christine Greene, Kris D. McCombe, Fatima Abdullahi Sidi, Stephen McQuaid, Stephen Cooke, Steven J. Hunter, Brian Herron, Márta Korbonits, Stephanie G. Craig, Jacqueline A. James\",\"doi\":\"10.1111/bpa.13285\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Pituitary neuroendocrine tumour Ki-67 proliferation index varies according to the number of tumour cells assessed. Consistent Ki-67 scoring approaches and re-evaluation of the recommended Ki-67 3% cut-off are required to clarify controversies in pituitary neuroendocrine tumour Ki-67 proliferation index assessment.\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":9290,\"journal\":{\"name\":\"Brain Pathology\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":5.8000,\"publicationDate\":\"2024-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669404/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bpa.13285\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Pathology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bpa.13285","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

垂体神经内分泌肿瘤的Ki-67增殖指数因评估的肿瘤细胞数量而异。为澄清垂体神经内分泌肿瘤 Ki-67 增殖指数评估中的争议，需要采用一致的 Ki-67 评分方法并重新评估推荐的 Ki-67 3% 临界值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

摘要图片

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Assessment of Ki-67 and mitoses in pituitary neuroendocrine tumours—Consistency counts

Pituitary neuroendocrine tumour Ki-67 proliferation index varies according to the number of tumour cells assessed. Consistent Ki-67 scoring approaches and re-evaluation of the recommended Ki-67 3% cut-off are required to clarify controversies in pituitary neuroendocrine tumour Ki-67 proliferation index assessment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Brain Pathology 医学-病理学

CiteScore

13.20

自引率

3.10%

发文量

审稿时长

6-12 weeks

期刊介绍： Brain Pathology is the journal of choice for biomedical scientists investigating diseases of the nervous system. The official journal of the International Society of Neuropathology, Brain Pathology is a peer-reviewed quarterly publication that includes original research, review articles and symposia focuses on the pathogenesis of neurological disease.